.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
UBS
Mallinckrodt
Covington
Novartis
Chubb
Express Scripts
Dow
Fish and Richardson
QuintilesIMS

Generated: September 19, 2017

DrugPatentWatch Database Preview

DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

Which patents cover Dextrose 5% And Electrolyte No. 48 In Plastic Container, and when can generic versions of Dextrose 5% And Electrolyte No. 48 In Plastic Container launch?

Dextrose 5% And Electrolyte No. 48 In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.

The generic ingredient in DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER is dextrose; magnesium chloride; potassium chloride; potassium phosphate, monobasic; sodium chloride; sodium lactate. There are eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dextrose; magnesium chloride; potassium chloride; potassium phosphate, monobasic; sodium chloride; sodium lactate profile page.

Summary for Tradename: DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list106,454
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER at DailyMed

Pharmacology for Tradename: DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare
DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER
dextrose; magnesium chloride; potassium chloride; potassium phosphate, monobasic; sodium chloride; sodium lactate
INJECTABLE;INJECTION017484-001Approved Prior to Jan 1, 1982RXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
US Army
Baxter
AstraZeneca
Farmers Insurance
Harvard Business School
QuintilesIMS
UBS
Federal Trade Commission
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot